Respir Med 248:108344 Karampatakis N, Karampatakis T, Galli-Tsinopoulou A, Kotanidou EP, Tsergouli K, Eboriadou-Petikopoulou M et al (2017) Impaired glucose metabolism and bronchial hyperresponsiveness in obese prepubertal asthmatic children
Verified Quality: Limitless Life guarantees high purity levels on all peptides, verified with Certificates of Analysis (COAs) from third-party labs
Dihexa represents a new frontier in how we support brain health across the lifespan
0.1% (placebo) Steady State: Achieved after 4-5 weeks of weekly dosing Safety: Nausea (68% at 4.5 mg), vomiting (32%), generally mild-moderate and transient Discontinuation: 14% discontinued due to GI adverse events Appetite Effects: Significant reductions in Visual Analogue Scale (VAS) hunger scores Publication: Lau DCW, et al
What changes is the label on the vial, the testing protocol (if any), and mostly the price